Partner Headlines - ECTE

  1. Morning Market Losers

    Benzinga
  2. Echo Therapeutics Mails Letter to Shareholders; Urges Not to ...

    Benzinga
  3. Echo Therapeutics Comments on Proxy Contest by Platinum Management ...

    Benzinga
  4. Platinum Management (NY) LLC Urges Stockholders to Take No Action ...

    Benzinga
  5. Echo Therapeutics Submits CE Mark Technical File to European ...

    Benzinga
  6. Morning Market Losers

    Benzinga
  7. Morning Market Movers

    Benzinga
  8. Echo Therapeutics Schedules Meeting with Platinum-Montaur Next ...

    Benzinga
  9. Echo Therapeutics Announces CEO, President and Chairman, Dr. ...

    Benzinga
  10. LifeTech Capital Reiterates Neutral Rating on Echo Therapeutics ...

    Benzinga
  11. Echo Therapeutics Prices 13.33M Share Offering @ $0.75/Share

    Benzinga
  12. Echo Therapeutics to Report Trial Results of Symphony tCGM System ...

    Benzinga
  13. Echo Therapeutics Prices 3.2M Share Offering @$0.95/Share

    Benzinga
  14. Stocks Hitting 52-Week Lows

    Benzinga
  15. Stocks Hitting 52-Week Lows

    Benzinga
  16. Echo Therapeutics Announces Proposed Public Offering

    Benzinga
  17. Echo Therapeutics Announces $20 Million Financing with Platinum-Montaur ...

    Benzinga
  18. Benzinga's Top Initiations

    Benzinga
  19. Echo Therapeutics Announces Positive Clinical Trial Results of ...

    Benzinga
  20. UPDATE: Wunderlich Securities Initiates Coverage of Echo Therapeutics ...

    Benzinga
  21. Echo Therapeutics Expands License Agreement with Ferndale Pharma

    Benzinga
  22. Echo Therapeutics Presents Positive Clinical Trial Results of ...

    Benzinga
  23. Benzinga's Top Downgrades With Color for May 14, 2012

    Benzinga
  24. Echo Therapeutics Announces Positive Clinical Trial Results of ...

    Benzinga
  25. Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM ...

    Benzinga
  26. LifeTech Has Strong Speculative Buy, $6 PT On Echo Therapeutics

    Benzinga
Trading Center